Previous efforts to determine changes in gene expression profiles following hormone treatment in MCF-7 [21-25,27] and ZR-75-1 [26] ER+ breast carcinoma cell lines have yielded a number of novel estrogen-responsive genes and demonstrated the utility of such genome-scale technologies in studying estrogen biology. Here, ESR1 is linked to breast carcinoma.